This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
21 Jul 2011

Drug Discovery Outsourcing Market Set to Grow, Report Says

The drug discovery outsourcing market has grown significantly over the past two decades and will be worth US$16.21bn by 2015.

In 2010, the global discovery outsourcing market was valued at US$8.30bn. According to a report by London-based business information provider Visiongain, the drug discovery outsourcing market has grown significantly over the past two decades and will be worth US$16.21bn by 2015,

 

A key market driver for outsourcing is cost reduction, the Drug Discovery Outsourcing: World Market 2011-2021 report says. Others include the reduction of time-to-market and the increased efficiency afforded by outsourcing drug discovery.

 

The need to outsource is a result of the significant financial challenges facing the global biopharmaceutical industry. The cost of bringing a drug to market has steadily risen over the past 20 years. This has put immense pressure on drug

Related News